1887
Editorial Open Access
Like 1
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.10.2200222
2022-03-10
2022-05-23
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.10.2200222
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/10/eurosurv-27-10-1.html?itemId=/content/10.2807/1560-7917.ES.2022.27.10.2200222&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Geneva: WHO; 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
  2. World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard. Geneva: WHO. [Accessed 10 March 2022]. Available from: https://covid19.who.int
  3. Statista. Impact of the coronavirus pandemic on the global economy - Statistics & Facts. Hamburg: Statista. [Accessed 05 Feb 2022]. Available from: https://www.statista.com/topics/6139/covid-19-impact-on-the-global-economy/
  4. Singh S, McNab C, Olson RM, Bristol N, Nolan C, Bergstrøm E, et al. How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic. Lancet. 2021;398(10316):2109-24.  https://doi.org/10.1016/S0140-6736(21)01897-3  PMID: 34762857 
  5. Kucharski AJ, Jit M, Logan JG, Cotten M, Clifford S, Quilty BJ, et al. Travel measures in the SARS-CoV-2 variant era need clear objectives. Lancet. 2022:S0140-6736(22)00366-X.  PMID: 35247312 
  6. Chua AQ, Al Knawy B, Grant B, Legido-Quigley H, Lee WC, Leung GM, et al. How the lessons of previous epidemics helped successful countries fight covid-19. BMJ. 2021;372(486):n486.  https://doi.org/10.1136/bmj.n486  PMID: 33707174 
  7. Chua AQ, Tan MMJ, Verma M, Han EKL, Hsu LY, Cook AR, et al. Health system resilience in managing the COVID-19 pandemic: lessons from Singapore. BMJ Glob Health. 2020;5(9):e003317.  https://doi.org/10.1136/bmjgh-2020-003317  PMID: 32938609 
  8. Han E, Tan MMJ, Turk E, Sridhar D, Leung GM, Shibuya K, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396(10261):1525-34.  https://doi.org/10.1016/S0140-6736(20)32007-9  PMID: 32979936 
  9. Jung AS, Haldane V, Neill R, Wu S, Jamieson M, Verma M, et al. National responses to covid-19: drivers, complexities, and uncertainties in the first year of the pandemic. BMJ. 2021;375:e068954.  https://doi.org/10.1136/bmj-2021-068954  PMID: 34840138 
  10. Haldane V, Jung AS, Neill R, Singh S, Wu S, Jamieson M, et al. From response to transformation: how countries can strengthen national pandemic preparedness and response systems. BMJ. 2021;375:e067507.  https://doi.org/10.1136/bmj-2021-067507  PMID: 34840139 
  11. Ko HK, Yu WK, Pan SW, Chen WC, Yang KY, Lin YT, et al. , Research Center for Epidemic Prevention—National Yang Ming Chiao Tung University (RCEP-NYCU). Consensus statement and recommendations on the treatment of COVID-19: 2021 update. J Chin Med Assoc. 2022;85(1):5-17. PMID: 34524227 
  12. Haldane V, Jung AS, De Foo C, Bonk M, Jamieson M, Wu S, et al. Strengthening the basics: public health responses to prevent the next pandemic. BMJ. 2021;375:e067510.  https://doi.org/10.1136/bmj-2021-067510  PMID: 34840134 
  13. Peeling RW, Wedderburn CJ, Garcia PJ, Boeras D, Fongwen N, Nkengasong J, et al. Serology testing in the COVID-19 pandemic response. Lancet Infect Dis. 2020;20(9):e245-9.  https://doi.org/10.1016/S1473-3099(20)30517-X  PMID: 32687805 
  14. World Health Organization (WHO). The Access to COVID-19 Tools (ACT) Accelerator. Geneva: WHO; 2020. Available from: https://www.who.int/initiatives/act-accelerator
  15. UNICEF. COVID-19 Vaccine Market Dashboard. New York City: UNICEF. [Accessed 05 March 2022]. Available from: https://www.unicef.org/supply/covid-19-vaccine-market-dashboard
  16. Swiss Federal Office of Public Health. The Swiss Confederation joins the COVAX initiative for the procurement of COVID-19 vaccines. Berne: Swiss Federal Offiec of Public Health; 2020. Available from: https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-80510.html
  17. Haldane V, De Foo C, Abdalla SM, Jung AS, Tan M, Wu S, et al. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med. 2021;27(6):964-80.  https://doi.org/10.1038/s41591-021-01381-y  PMID: 34002090 
  18. The Independent Panel for Pandemic Preparedness and Response (IPPPR). Second report on progress: prepared by the Independent Panel for Pandemic Preparedness and Response for the WHO Executive Board, January 2021. The Independent Panel; 2021. Available from: https://theindependentpanel.org/wp-content/uploads/2021/01/Independent-Panel_Second-Report-on-Progress_Final-15-Jan-2021.pdf
  19. Smith GE, Elliot AJ, Lake I, Edeghere O, Morbey R, Catchpole M, et al. , Public Health England Real-time Syndromic Surveillance Team. Syndromic surveillance: two decades experience of sustainable systems - its people not just data! Epidemiol Infect. 2019;147:e101.  https://doi.org/10.1017/S0950268819000074  PMID: 30869042 
  20. Antia R, Halloran ME. Transition to endemicity: Understanding COVID-19. Immunity. 2021;54(10):2172-6.  https://doi.org/10.1016/j.immuni.2021.09.019  PMID: 34626549 
  21. Guerrisi C, Turbelin C, Blanchon T, Hanslik T, Bonmarin I, Levy-Bruhl D, et al. Participatory Syndromic Surveillance of Influenza in Europe. J Infect Dis. 2016;214(suppl_4):S386-92.  https://doi.org/10.1093/infdis/jiw280  PMID: 28830105 
  22. Medema G, Been F, Heijnen L, Petterson S. Implementation of environmental surveillance for SARS-CoV-2 virus to support public health decisions: Opportunities and challenges. Curr Opin Environ Sci Health. 2020;17:49-71.  https://doi.org/10.1016/j.coesh.2020.09.006  PMID: 33024908 
  23. Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626-36.  https://doi.org/10.1038/s41577-021-00592-1  PMID: 34373623 
  24. Office for National Statistics. Antibodies against coronavirus (COVID-19) 2022 [Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/antibodies accessed 24th February 2022.
  25. Lal A, Erondu NA, Heymann DL, Gitahi G, Yates R. Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage. Lancet. 2021;397(10268):61-7.  https://doi.org/10.1016/S0140-6736(20)32228-5  PMID: 33275906 
  26. Centers for Disease Control and Prevention (CDC). What is One Health? Atlanta: CDC. [Accessed 10 Mar 2022]. Available from: https://www.cdc.gov/onehealth/basics/index.html
  27. Singh S, Bartos M, Abdalla S, Legido-Quigley H, Nordström A, Sirleaf EJ, et al. Resetting international systems for pandemic preparedness and response. BMJ. 2021;375:e067518.  https://doi.org/10.1136/bmj-2021-067518  PMID: 34840131 
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error